21st Century Treatment of Heart Failure 2008

Agenda
Thursday | Friday | Saturday

For event information please call:
Mavi Golsmith , Jamie Belkin Events, 216-932-3448 | mavi@jamiebelkin.com

Thursday, October 16th
6:30 pm - 8:30 pm	Registration and Attendee Reception
Friday, October 17th
7:55 am	Welcome and Announcements
Session I:	21st Century Treatment of Heart Failure: Insights into Critical Medical and Surgical Issues Moderators: Randall Starling, MD & James W. Long, MD, PhD
8:00 am	Predicting Mortality in Heart Failure: Which Model? - Keith D. Aaronson, MD
8:20 am	Indications for ICD and CRT: Too Much or Too Little? - Bruce D. Lindsay, MD
8:40 am	What Is the Role of BNP in Selecting Patients for Heart Failure Surgery? - Jean G. Dumesnil, MD
9:00 am	Do We Need Better Organ Preservation or Better Immunosuppression in Cardiac Transplantation? - Kenneth R. McCurry, MD
9:20 am	Registries: Will They Help Us Provide Better Evidence Based Patient Care? From ADHERE to INTERMACS - James B. Young, MD
9:40 am	Panel Discussion
10:10 am	Break

Session II:	Complex Cases in Heart Failure Moderators: Mark S. Slaughter, MD & David O. Taylor, MD
10:30 am	Case #1 Discussants: James B. Young, MD & Michael A. Acker, MD
11:00 am	Case #2 Discussants: Mariel Jessup, MD & O. Howard Frazier, MD
11:30 am	Case #3 Discussants: Maria Rosa Costanzo, MD & Benjamin C. Sun, MD
12:00 pm	Lunch

Session III:	Management of Acute MI and Cardiogenic Shock Moderators: Soon J. Park, MD & Keith D. Aaronson, MD
1:15 pm	Acute MI Management for the Non–Interventionalist: Aspirin to Aspiration - Samir Kapadia, MD
1:35 pm	Coronary Revascularization in Cardiogenic Shock: Patient Selection - Joseph F. Sabik, MD
1:55 pm	Moving Beyond “Conventional” Therapy Using Data from The SHOCK Trial - Soon J. Park, MD
2:15 pm	Mechanical Circulatory Support Should be Utilized for Acute Myocardial Infarction (Point/Counter–Point) Saving Lives: Reynolds M. Delgado III, MD Spending Money: David S. Feldman, MD, PhD
2:45 pm	Panel Discussion
3:05 pm	Break

Session IV:	Cardiac Remodeling: Does It Happen and Is It Important? Moderators: Christine S. Moravec, PhD & Randall C. Starling, MD, MPH
3:30 pm	Do Evidence Based Medications Do Anything? - Randall C. Starling, MD, MPH
3:45 pm	Can Surgery Alone Do Anything? - Michael A. Acker, MD
4:00 pm	What’s on the Horizon: Clenbuterol and LVADs: The HARPS Trial - Leslie W. Miller, MD
4:15 pm	Relevant Differences Between Acute MI and Chronic Heart Failure for Stem Cell Therapy - Marc Penn, MD, PhD
4:30 pm	Biopolymers: An Innovative Treatment for Heart Failure? - Hani N. Sabbah, PhD
4:45 pm	Panel Discussion
5:05 pm	Adjourn
5:30 pm – 7:00 pm	Reception \| Poster Viewing \| Exhibits

Saturday, October 18th
Session V:	Quality Metrics and Their Impact on Cardiovascular Disease Practice: Clinician, Payor, and Consumer Perspective Moderators: Clyde W. Yancy, MD & Nicholas G. Smedira, MD
8:00 am	Overview: The Surgery Was Successful, but the Patient Died - Nicholas G. Smedira, MD
8:15 am	Improving Quality in Cardiac Surgery: More than Reducing Mortality - Thoralf M. Sundt, MD
8:30 am	Are Specialty Heart Centers Better at Treating Acute MI and Heart Failure? - Clyde W. Yancy, MD
8:45 am	Improving Outcomes in Thoracic Organ Transplantation: What Can or Will UNOS and HHS Do? - Robert S.D. Higgins, MD
9:15 am	The Payor Perspective Allan T. Khoury, MD, PhD Chief Medical Officer, Whole Health Management, Inc.
9:30 am	The Patient Experience and Its Impact on Quality - M. Bridget Duffy, MD
9:45 am	Panel Discussion
10:15 am	Break

Session VI:	Cardio Renal Interactions: Which Organ is Really the Most Important? Moderators: Richard A. Fatica, MD & James C. Fang, MD
10:45 am	New Insights into Cardio–Renal Interactions in Heart Failure - W. H. Wilson Tang, MD
11:00 am	Current and Future Pharmacologic Therapy for Renal Preservation in Heart Failure - Michael M. Givertz, MD
11:15 am	Renal Dysfunction and MCS: What Does it Mean and What to Do About It - Nader Moazami, MD
11:30 am	Heart–Kidney Transplantation: Why, When, and How - Gonzalo Gonzalez-Stawinski, MD
11:45 am	Panel Discussion
12:15 pm	Lunch

Session VII:	Pump Selection: Who, When, and What? Moderators: James Young, MD & O. Howard Frazier, MD
1:30 pm	Continuous Flow vs. Pulsatile Flow Pumps: Are There Differences in Outcomes for Bridge to Transplant and Destination Therapy? - Joseph G. Rogers, MD
1:50 pm	Is There A Role For Partial Assist Devices? - Reynolds M. Delgado III, MD
2:10 pm	Mortality on the Bridge to Transplant List: Is There a Role for Increased Left Ventricular Assist Device Use in Less Ill Patients? - Francis D. Pagani, MD, PhD
2:30 pm	Improving Current DT Outcomes: Patient Selection, Patient Management, Or New Pump Technology: Which One Is It? - James K. Kirklin, MD
2:50 pm	Panel Discussion

Session VIII:	Contemporary Experience With New Pumps (8 mins each) Moderators: Gonzalo Gonzalez-Stawinski, MD & Kiyotaka Fukamachi, MD, PhD
3:10 pm	DuraHeart - Francis D. Pagani, MD, PhD Jarvik - O. Howard Frazier, MD Synergy - Michael A. Acker, MD Cancion/Exceleras - Paul J. Mather, MD Heartware - Mark S. Slaughter, MD Levacor - James W. Long, MD, PhD Centrimag - Francisco A. Arabia, MD VentraAssist - Ranjit John, MD DeBakey - William L. Holman, MD Impella - Mark B. Anderson, MD CPD - Robert D. Dowling, MD Heart Mate II - Nicholas Smedira, MD EVAHEART - Hiroyuki Tsukui, MD
4:45 pm	Adjourn

	About The Cleveland Clinic Center for Continuing Education \| Call or Email Us \| About The Cleveland Clinic

	Live Cleveland Clinic CME Courses \| Regularly Scheduled Series (RSS) Registration \| Regulary Scheduled Series (RSS) Schedule (pdf)

	Disease Management Project Clinical Decisions Cases \| Hepatitis C Management \| Managing Problem Patients with Anti-TNF Inhibitors \| More

	Medicine Today Series \| B Cell Series \| Emerging Therapies in Heart Disease Webcast Series \| More

	Disease Management Project \| CCJM 1-Minute Consult \| Pharmacotherapy Update Newsletter \| Algorithms for the MICU \| More